![]() “doctor shopping”) and reducing diversion of controlled substances. The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. ![]() Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. This may be because those declined opioid prescriptions turn to street drugs, whose potency and contaminants carry greater overdose risk. While prescription of opioids has decreased with PMP use, overdose deaths in many states have actually increased, with those states sharing data with neighboring jurisdictions or requiring reporting of more drugs experiencing highest increases in deaths. All states have implemented PDMPs, although evidence for the effectiveness of these programs is mixed. The majority of PMPs are authorized to notify law enforcement agencies or licensing boards or physicians when a prescriber, or patients receiving prescriptions, exceed thresholds established by the state or prescription recipient exceeds thresholds established by the State. The database, whose use is required by State law, typically requires prescribers and pharmacies dispensing controlled substances to register with their respective state PMPs and (for pharmacies and providers who dispense from their offices) to report the dispensation of such prescriptions to an electronic online database. Most US health care workers support the idea of PMPs, which intend to assist physicians, physician assistants, nurse practitioners, dentists and other prescribers, the pharmacists, chemists and support staff of dispensing establishments. PMPs are meant to help prevent adverse drug-related events such as opioid overdoses, drug diversion, and substance abuse by decreasing the amount and/or frequency of opioid prescribing, and by identifying those patients who are obtaining prescriptions from multiple providers (i.e., "doctor shopping") or those physicians overprescribing opioids. In the United States, prescription monitoring programs ( PMPs) or prescription drug monitoring programs ( PDMPs) are state-run programs which collect and distribute data about the prescription and dispensation of federally controlled substances and, depending on state requirements, other potentially abusable prescription drugs. Authorized users agree that they will not provide access to any other individuals, including members of their staff unless and until they are authorized as delegates.Ī prescriber or pharmacist who accesses or discloses information for any purpose other than providing healthcare to a current patient or verifying the record of prescriptions issued by the prescriber, or who allows any other individuals to access the information using the prescriber’s or pharmacist’s own access codes, is subject to civil penalties for each offense and disciplinary action by the prescriber’s or pharmacist’s professional licensing board.Īny individual who suspects that another individual or entity has accessed or disclosed patient information in violation should immediately contact the Administrator or the Executive Director and CSMP Administrator. ![]() Prescribers and pharmacists authorized to access the patient information, must certify before each search that they are seeking data solely for the purpose of providing healthcare to current patients. ![]() The data will be accessible to Prescribers and Dispensers who have been credentialed and who agree to confidentiality requirements for access to and the use of this information. The data is housed in a high security, HIPAA-compliant database. The West Virginia Board of Pharmacy and its private contractor keep patient information strictly confidential, in compliance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |